Logos Global Management »

Tango Therapeutics shares owned by Logos Global Management

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by Logos Global Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.0M 950k 8.40

More positions owned by Logos Global Management

Revolution Medicines Call Option (RVMD)
Ideaya Biosciences Call Option (IDYA)
Akero Therapeutics (AKRO)
Arvinas Ord (ARVN)
Ocular Therapeutix (OCUL)
Cidara Therapeutics Com New (CDTX)
Verastem Com New (VSTM)
Abivax Sa Sponsored Ads (ABVX)
Janux Therapeutics (JANX)
Erasca (ERAS)
Maze Therapeatics (MAZE)
Olema Pharmaceuticals (OLMA)
Immunocore Hldgs Ads (IMCR)
Dyne Therapeutics (DYN)
Disc Medicine (IRON)

View all positions for Logos Global Management

Top funds holding Tango Therapeutics

Trv Gp Iv
Farallon Capital Management
EcoR1 Capital
Boxer Capital Management
TCG Crossover Management
Woodline Partners
Siren
BlackRock
Nextech Invest
Vanguard Group
Gilead Sciences
T. Rowe Price Investment Management
Balyasny Asset Management
State Street Corporation
Paradigm Biocapital Advisors

View all funds holding Tango Therapeutics